The HIV Second-Line Therapy AntiRetroviral Study in Patients Who Failed NNRTI-Based Regimens.

Trial Profile

The HIV Second-Line Therapy AntiRetroviral Study in Patients Who Failed NNRTI-Based Regimens.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2014

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine; Tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HIV-STAR
  • Most Recent Events

    • 03 Jul 2013 Results on predictors of renal insufficiency presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
    • 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
    • 08 Mar 2012 Substudy assessing neurocognitive impairment outcomes presented at the 19th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top